| Objective:To observe the clinical effect of Fu Luo Fang(self-made prescription)on the early stage of lower extremity arteriosclerosis obliterans phlegm and obstruction of collaterals,and provide new therapeutic drugs for the patients with early phlegm and obstruct collaterals of the lower extremity arteriosclerosis obliterans.Method:This study selected 60 outpatients who had peripheral vascular diseases in the First Affiliated Hospital of Heilongjiang University Of Chinese Medicine from May 2017 to February 2018.They were randomly divided into 2 groups,with 30 cases in each group.The treatment group was treated with Fu Luo Fang granule and washed with warm water for two times a day.The control group was treated with 5 tablets of Tongsai Mai,orally,three times a day.After 12 weeks of treatment,the clinical manifestations,resting ABI index,calf infrared thermography and overall efficacy were compared between the two groups.Result:(1)The treatment group was better than the control group(P<0.05),the treatment group was superior to the control group(P<0.05),and the two groups after the treatment were compared(P>0.05).(2)The infrared thermography of the legs improved after treatment,and the treatment group was better than the control group(P<0.05).(3)There was no significant difference in resting ABI index between the treatment group and the control group after treatment(P>0.05),and the treatment group was better than the control group(P<0.05).(4)After the treatment,the total effective rate of the treatment group was 80%,and the total effective rate of the control group was 66.7%.The treatment group was better than the control group(P<0.05).Conclusion:1.Fu Luo collaterals can improve the clinical manifestations,the infrared thermography and the overall efficacy of the phlegm stasis blocking type in the early stage of arteriosclerosis obliterans of the lower extremities.2.Fu Luo prescription is better than Tongsaimai Tablet in the treatment of early lower limb arteriosclerosis obliterans with phlegm stasis blocking type. |